Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $6.6 million.

  • Pediatrix Medical's Cash from Investing Activities rose 25223.61% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year increase of 7831.43%. This contributed to the annual value of -$35.4 million for FY2024, which is 2650.7% up from last year.
  • Pediatrix Medical's Cash from Investing Activities amounted to $6.6 million in Q3 2025, which was up 25223.61% from -$7.2 million recorded in Q2 2025.
  • Pediatrix Medical's Cash from Investing Activities' 5-year high stood at $16.4 million during Q2 2021, with a 5-year trough of -$43.6 million in Q3 2021.
  • In the last 5 years, Pediatrix Medical's Cash from Investing Activities had a median value of -$11.4 million in 2023 and averaged -$10.7 million.
  • Within the past 5 years, the most significant YoY rise in Pediatrix Medical's Cash from Investing Activities was 27068.84% (2021), while the steepest drop was 183492.63% (2021).
  • Pediatrix Medical's Cash from Investing Activities (Quarter) stood at -$15.6 million in 2021, then increased by 27.87% to -$11.2 million in 2022, then dropped by 10.52% to -$12.4 million in 2023, then soared by 84.4% to -$1.9 million in 2024, then surged by 440.76% to $6.6 million in 2025.
  • Its Cash from Investing Activities was $6.6 million in Q3 2025, compared to -$7.2 million in Q2 2025 and -$7.5 million in Q1 2025.